Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance

Journal of Clinical Investigation

Volumn 104, Issue 8, 1999, Pages 1087-1096

  Parks, Elizabeth J ^a   Krauss, Ronald M ^b   Christiansen, Mark P ^c   Neese, Richard A ^c   Hellerstein, Marc K ^c,d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; DIET RESTRICTION; FAT INTAKE; FATTY ACID METABOLISM; HUMAN; HUMAN EXPERIMENT; LIPOGENESIS; LIPOPROTEIN SYNTHESIS; METABOLIC REGULATION; NORMAL HUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032726283     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6572     Document Type: Article

References (62)

1. Connor, W.E., and Connor, S.L. 1997. Should low-fat, high-carbohydrate diets be recommended for everyone? N. Engl. J. Med. 337:562-563.
2. Katan, M.B., Grundy, S.M., and Willett, W.C. 1997. Beyond low-fat diets. N. Eng. J. Med. 337:563-566.
3. Ornish, D. 1998. Low-fat diets [letter]. N. Engl. J. Med. 338:128.
4. Rudel, L.L. 1998. Low-fat diets [letter]. N. Engl. J. Med. 338:127.
5. Manning, A. Study: lowfat diets can go too far. USAToday. November 12, 1997. p. 1D.
6. Austin, M.A., Holkanson, J.E., and Edwards, K.L. 1998. Hypertriglyceridemia as a cardiovascular risk factor. Am. J. Cardiol. 81:7B-12B.
7. Cianflone, K., Dahan, S., Monge, J.C., and Sniderman, A.J. 1992. Pathogenesis of carbohydrate-induced hypertriglyceridemia using HepG2 cells as a model system. Arterioscler. Thromb. 12:271-277.
8. Boren, J., Wettesten, M., Rustaeus, S., Andersson, M., and Olofsson, S.-O. 1993. The assembly and secretion of apoB-100 containing lipoproteins. Biochem. Sci. Trans. 21:487-493.
9. Wu, X., Shang, A., Jiang, H., and Ginsberg, H. 1996. Low rates of apoB secretion from HepG2 cells result from reduced delivery of newly synthesized triglyceride to a "secretion-coupled" pool. J. Lipid. Res. 37:1198-1206.
10. Gibbons, G.F., and Wiggins, D. 1995. Intracellular triacylglycerol lipase: its role in theassembly of hepatic very-low-density-lipoprorein (VLDL). In Advances in enzyme regulation. Volume 35. Elsevier Science Ltd. Oxford, United Kingdom. 179-198.
11. Reaven, G.M., Lerner, R.L., Stern, M.P., and Farquhar, J.W. 1967. Role of insulin in endogenous hypertriglyceridemia. J. Clin. Invest. 46:1756-1767.
12. Ginsberg, H., Olefsky, J.M., Kimmerling, G., Crapo, P., and Reaven, G.M. 1976. Induction of hypertriglyceridemia by a low-fat diet. J. Clin. Endocrinol. Metab. 42:729-735.
13. Reaven, G.M., and Bernstein, R.M. 1978. Effect of obesity on the relationship between very low density lipoprotein production rate and plasma triglyceride concentration in normal and hypertriglyceridemic subjects. Metabolism. 27:1047-1054.
14. Melish, J., Le, N.A., Ginsberg, H., Brown, W.U., and Steinberg, D. 1980. Dissociation of the rates of production of apoprotein B and TG of very-low density lipoproteins during high-carbohydrate feeding in man. Am. J. Physiol. 239:E354-E362.
15. Huff, M.W., and Nestel, P.J. 1982. Metabolism of apolipoproteins CII, CIII1, CIII2 and VLDL-B in human subjects consuming high carbohydrate diets. Metabolism. 31:493-498.
16. Knirtle, J.L., and Ahrens, E.K.J. 1964. Carbohydrate metabolism in two forms of hyperglyceridemia. J. Clin. Invest. 43:485-495.
17. Kuo, P.T., and Bassett, D.R. 1965. Dietary sugar in the production of hyperglyceridemia. Ann. Intern. Med. 62:1199-1212.
18. Reaven, G.M., Hill, D.B., Gross, R.C., and Farquhar, J.W. 1965. Kinetics of triglyceride turnover of very low density lipoproteins in human plasma. J. Clin. Invest. 44:1826-1833.
19. Farquhar, J.W., Frank, A., Gross, R.C., and Reaven, G.M. 1966. Glucose, insulin, and triglyceride responses to high and low carbohydrate diets in man J. Clin. Invest. 45:1648-1656.
20. Barter, P.J., Nestel, P.J., and Carroll, K.F. 1972. Precursors of plasma triglyceride fatty acid in humans. Effects of glucose consumption, clofibrate administration, and alcoholic fatty liver. Metabolism. 21:117-124.
21. Abbott, W.G., et al. 1990. Effect of a high-carbohydrate, low-saturated-fat diet on apolipoprotein B and triglyceride metabolism in Pima Indians. J. Clin. Invest. 86:642-650.
22. Nestel, P.J., Carroll, K.F., and Havenstein, N. 1970. Plasma triglyceride response to carbohydrates, fats and calorie intake. Metabolism. 19:1-18.
23. Boberg, J., Carlson, L.A., Freyschuss, U., Lassers, B.W., and Wahlqvist, M.L. 1972. Splanchnic secretion rates of plasma triglycerides and total and splanchnic turnover of plasma free fatty acids in men with normo- and hypertriglyceridaemia. Eur. J. Clin. Invest. 2:454-466.
24. Boberg, J., Carlson, L.A., and Freyschuss, U. 1972. Determination of splanchnic secretion rate of plasma triglycerides and of total and splanchnic turnover of plasma free fatty acids in man. Eur. J. Clin. Invest. 2:123-132.
25. Schonfeld, G. 1970. Changes in the composition of very low density lipoprotein during carbohydrate induction in man. J. Lab. Clin. Med. 75:206-211.
26. Ginsberg, H.N., Le, N.A., Melish, J., Steinberg, D., and Brown, W.V. 1981. Effect of a high carbohydrate diet on apoprotein-B catabolism in man. Metabolism. 30:347-353.
27. Hudgins, L.C., et al. 1996. Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J. Clin. Invest. 97:1-11.
28. Hellerstein, M.K., et al. 1991. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J. Clin. Invest. 87:1841-1852.
29. Glueck, C.J., Levy, R.I., and Fredrickson, D.S. 1969. Immunoreactive insulin, glucose intolerance, and carbohydrate inducibility in types II, III, IV and V hyperlipoproteinemia. Diabetes. 18:739-747.
30. Christie, W.W. 1982. Lipid analysis. Pergamon Press. New York, NY. 52-53.
31. Wolfe, R.R. 1992. Radioactive and stable isotope tracers in biomedicine. John Wiley & Sons. New York, NY. 424-426.
32. Cheung, M.C., and Albers, J.J. 1977. The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay. J. Clin. Invest. 60:43-50.
33. Bergeron, N., Kotite, L., and Havel, R.J. 1996. Simultaneous quantification of apolipoproteins B-100. B-48, and E separated by SDS-PAGE. Methods Enzymol. 268:82-94.
34. Hatch, F.T. 1968. Practical methods for plasma lipoprotein analysis. Adv. Lipid Res. 6:1-68.
35. Parks, E.J., et al. 1998. Reduced susceptibility of LDL from patients participating in an intensive atherosclerosis treatment program. Am. J. Clin. Nutr. 68:778-785.
36. Marzetta, C.A., Foster, D.M., and Brunzell, J.D. 1990. Conversion of plasma VLDL and IDL precursors into various LDL subpopulations using density gradient ultracentrifugation. J. Lipid. Res. 31:975-984.
37. Musliner, T.A., Giotas, C., and Krauss, R.M. 1986. Presence of multiple subpopulations of lipoproteins of intermediate density in normal subjects. Arteriosclerosis. 6:79-87.
38. 13C1]glycerol. J. Lipid Res. 39:2319-2328.
39. Egusa, G., Brady, D., Grundy, S.M., and Howard, B.V. 1983. Isopropanol precipitation method for the determination of apoB specific activity and plasma concentrations during metabolic studies of VTUL and LDL apoB. J. Lipid Res. 24:1261-1267.
40. Zilversmit, D.B. 1960. The design and analysis of isotope experiments. Am. J. Med. 29:832-848.
41. Grundy, S.M., Mok, H.Y.I., Zech, L., Steinberg, D., and Berman, M. 1979. Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia. J. Lipid. Res. 63:1274-1283.
42. Ryan, W.G., and Schwarte, T.B. 1965. Dynamics of plasma triglyceride turnover in man. Metabolism. 14:1243-1254.
43. Hellerstein, M.K. 1995. Methods for measurement of fatty acid and cholesterol metabolism. Curr. Opin. Lipidol. 6:172-181.
44. Jequier, E., Acheson, K., and Schutz, Y., 1987. Assessment of energy expenditure and fuel utilization in man. Annu. Rev. Nutr. 7:187-208.
45. Hudgins, L.C., Siedman, C.E., Diakun, J., and Hirsch, J. 1998. Human fatty acid synthesis is reduced after the substitution of dietary starch for sugar. Am. J. Clin. Nutr. 67:631-639.
46. Lithell, H., Jacobs, I., Vessby, B., Hellsing, K., and Karlsson, J. 1982. Decrease of lipoprotein lipase activity in skeletal muscle in man during a short-term carbohydrate-rich dietary regimen; with special reference to HDL-cholesterol apolipoprotein and insulin concentrations. Metabolism. 31:994-998.
47. Farese, R.V., Jr., Yost, T.J., and Eckel, R.H. 1991. Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Metabolism. 40:214-216.
48. Dreon, D.M., Fernstrom, H.A., Miller, B., and Krauss, R.M. 1994. Low-density lipoprotein subclass pattern and lipoprotein response to a reduced-fat diet in men. FASEB J. 8:121-126.
49. Barter, P.J., and Nestel, P.J. 1973. Precursors of plasma triglyceride fatty acids in obesity. Metabolism. 22:779-785.
50. Havel, R.J., Kane, J.P., Segel. E.O., and Basso, L.V. 1970. Splanchnic metabolism of free fatty acids and production of triglyceride of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans J. Clin. Invest. 49:2017-2035.
51. Kral, J.G., Lundholm, K., Bjorntorp, P., Sjostrom, L., and Schersren, T. 1977. Hepatic lipid metabolism in severe human obesity. Metabolism. 26:1025-1031.
52. Zelman, S. 1952. The liver in obesity. Arch. Intern. Med. 90:141-156.
53. Bjorntorp, P. 1988. Are regional metabolic differences of adipose tissue responsible for different risks of obesity? Horm. Metah. Res. Suppl. 19:23-25.
54. Micheli, H., Carlson, L.A., and Hallberg, D. 1969. Comparison of lipolysis in human subcutaneous and omental adipose tissue with regard to effects of noradrenaline, theophylline, prostaglandin E and age. Acta Chir. Scand. 135:663-670.
55. Fujioka, S., Matsuzawa, Y., Tokunaga, K., and Tarui, S. 1987. Contributions of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 36:54-59.
56. Egusa, G., Belrz, W.F., Grundy, S.M., and Howard, B.V. 1985. Influence of obesity on the metabolism of apolipoprotein B in humans. J. Clin. Invest. 76:596-603.
57. Kissebah, A.H., Alfarsi, S., and Adams, P.W. 1981. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipidemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Metabolism. 30:856-868.
58. Roust, L.R., Kottke, B.A., and Jensen, M.D. 1994. Serum lipid responses to a eucaloric high-complex carbohydrate diet in different obesity phenotypes. Mayo Clin. Proc. 69:930-936.
59. Windler, E., et al. 1996. Differences in the mechanisms of uptake and endocytosis of small and large chylomicron remnants by rat liver. Hepatology. 24:344-351.
60. Hultin, M., Savonen, R., and Olivecrona, T. 1996. Chylomicron metabolism in rats: lipolysis, recirculation of core lipids as analyzed by compartmental modelling. J. Lipid Res. 37:1022-1036.
61. Karpe, F., Olivecrona, T., Hamsten, A., and Hultin, M. 1997. Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants. J. Lipid Res. 38:949-961.
62. Miller, M. 1998. Is hypertriglyceridaemia an independent risk factor for coronary heart disease? Eur. Heart J. 19(Suppl. H):H18-H22.